HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells.

Abstract
Tissue hypoxemia is common in several pathological diseases, including vaso-occlusion in sickle cell disease and myocardial infarction. One finds increased presence of leukocytes during lung injury and at sites of inflammation in vascular endothelium. In this study, we used human pulmonary microvascular endothelial cells and human dermal microvascular endothelial immortalized cell line to delineate the cellular signaling mechanism of hypoxia- and CoCl2 (a mimetic of hypoxia)-induced IL-8 expression, and the latter's role in chemotaxis of polmorphonuclear neutrophils. We show that hypoxia- and CoCl2-induced IL-8 mRNA and protein expression involved activation of PI3K/Akt and p38 MAPK, but not MEK kinase. Analysis of some transcription factors associated with IL-8 promoter revealed that hypoxia and CoCl2 increased DNA-binding activity of hypoxia-inducible factor-1alpha (HIF-1alpha), NF-kappaB, and AP-1. In addition, we show that hypoxia- and CoCl2-induced IL-8 expression requires activation of HIF as demonstrated by the following: 1) EMSA; 2) transfection studies with IL-8 promoter reporter constructs with mutation in HIF-1alpha binding site; 3) attenuation of IL-8 expression by both HIF-1alpha small interfering RNA and R59949; 4) augmentation of IL-8 expression by either transfection with HIF-prolyl hydroxylase-2 small interfering RNA or overexpression of HIF-1alpha; and 5) chromatin immunoprecipitation analysis. Moreover, conditioned medium from hypoxia-treated endothelial cells augmented chemotaxis of neutrophils, due to release of IL-8. These data indicate that hypoxia-induced signaling in vascular endothelium for transcriptional activation of IL-8 involves PI3K/Akt, p38 MAPK, and HIF-1alpha. Pharmacological agents, which inhibit HIF-1alpha, may possibly ameliorate inflammation associated with hypoxia in pathological diseases.
AuthorsKyoung S Kim, Vikram Rajagopal, Caryn Gonsalves, Cage Johnson, Vijay K Kalra
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 177 Issue 10 Pg. 7211-24 (Nov 15 2006) ISSN: 0022-1767 [Print] United States
PMID17082639 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Chemokine CCL2
  • Chromones
  • Flavonoids
  • Hypoxia-Inducible Factor 1
  • Imidazoles
  • Interleukin-8
  • Morpholines
  • Protein Kinase Inhibitors
  • Pyridines
  • RNA, Messenger
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Cobalt
  • cobaltous chloride
  • SB 203580
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
Topics
  • Base Sequence
  • Cell Line, Transformed
  • Cells, Cultured
  • Chemokine CCL2 (biosynthesis)
  • Chemotaxis, Leukocyte (immunology)
  • Chromones (pharmacology)
  • Cobalt (physiology)
  • Endothelial Cells (immunology, metabolism)
  • Endothelium, Vascular (cytology, immunology, metabolism)
  • Flavonoids (pharmacology)
  • Humans
  • Hypoxia (metabolism)
  • Hypoxia-Inducible Factor 1 (physiology)
  • Imidazoles (pharmacology)
  • Interleukin-8 (antagonists & inhibitors, biosynthesis, genetics)
  • Molecular Sequence Data
  • Morpholines (pharmacology)
  • Protein Kinase Inhibitors (pharmacology)
  • Pulmonary Artery (cytology, immunology, metabolism)
  • Pyridines (pharmacology)
  • RNA, Messenger (antagonists & inhibitors, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: